Implementation research for promoting access and rational use of antibiotics for children: lessons learnt from Tanzania.


Journal

JAC-antimicrobial resistance
ISSN: 2632-1823
Titre abrégé: JAC Antimicrob Resist
Pays: England
ID NLM: 101765283

Informations de publication

Date de publication:
Apr 2023
Historique:
medline: 24 4 2023
pubmed: 24 4 2023
entrez: 24 04 2023
Statut: epublish

Résumé

Implementation research (IR) has proved to be a potential catalyst in facilitating the uptake of evidence-based innovations into routine practices and thereby maximizing public health outcomes. IR not only focuses on the effectiveness of the innovations but also identifies and addresses the barriers and facilitators to maximize their uptake into routine practices. This article describes the processes undertaken to implement a research project aimed at promoting access and rational use of antibiotics for children (PARAC). It also provides an overview of the lessons learnt during its implementation in Tanzanian hospital and community settings.

Identifiants

pubmed: 37090916
doi: 10.1093/jacamr/dlad045
pii: dlad045
pmc: PMC10116604
doi:

Types de publication

Journal Article Review

Langues

eng

Pagination

dlad045

Informations de copyright

© The Author(s) 2023. Published by Oxford University Press on behalf of British Society for Antimicrobial Chemotherapy.

Déclaration de conflit d'intérêts

During the workshop discussions, especially when the stakeholders were formulating actionable recommendations, there were always facilitator (in favour) and barrier (against) sides. However, conflict of interest among the stakeholders is something that needs to be clearly stated (noted) at the beginning of the IR process. For example, during the discussion on whether to include rapid diagnostic tests (RDTs) in the community pharmacies, there were conflicting interests between different professionals (pharmacy, medical and laboratory medicine). Some stakeholders thought that including RDTs in the community pharmacies was shifting the role of pharmacies from being dispensing outlets to health centres.

Références

Expert Opin Drug Saf. 2021 Nov;20(11):1375-1390
pubmed: 33999733
Lancet. 2018 Nov 17;392(10160):2214-2228
pubmed: 30314860
Antimicrob Resist Infect Control. 2019 May 28;8:87
pubmed: 31161034
Antibiotics (Basel). 2021 Apr 06;10(4):
pubmed: 33917430
BMC Public Health. 2012 Oct 24;12:904
pubmed: 23095365
J Eval Clin Pract. 2019 Jun;25(3):373-380
pubmed: 30632246
Bull World Health Organ. 2017 Feb 1;95(2):87
pubmed: 28250505

Auteurs

George M Bwire (GM)

Muhimbili University of Health and Allied Sciences, P.O. Box 65001, Dar es Salaam, Tanzania.

Upendo O Kibwana (UO)

Muhimbili University of Health and Allied Sciences, P.O. Box 65001, Dar es Salaam, Tanzania.

Lilian Nkinda (L)

Muhimbili University of Health and Allied Sciences, P.O. Box 65001, Dar es Salaam, Tanzania.

Betty A Maganda (BA)

Muhimbili University of Health and Allied Sciences, P.O. Box 65001, Dar es Salaam, Tanzania.

Mathew Mganga (M)

President's Office-Regional Administration and Local Government, P.O. Box 1923, Dodoma, Tanzania.

Arapha Bashir Nshau (AB)

Pharmacy Council, NHIF Building, 1st Floor, UDOM Road, P.O. Box 1277, Dodoma, Tanzania.

Oliver Williams (O)

Wellcome Trust, 215 Euston Road, London NW1 2BE, UK.

Janet Midega (J)

Wellcome Trust, 215 Euston Road, London NW1 2BE, UK.

Elevanie Nyankesha (E)

United Nations Children's Fund, New York Headquarter office, 3 United Nations Plaza, New York, NY 10017, USA.

Robert W Scherpbier (RW)

United Nations Children's Fund, Bâtiment BIT, Route des Morillons 4, CH-1211, Geneva 22, Switzerland.

Classifications MeSH